SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rocketman who wrote (484)3/11/1997 10:15:00 AM
From: William Presti   of 1172
 
In my last post I passed along some information about milestone
payments Chemtrak would receive from Astra-Merck and Selfcare.
I did not find out what the amounts are, but my GUESS is that
combined they are in the 500K - 1000K range. We'll see. What I
am concerned about recently is Selfcare and its ability to deliver on
their end of the Chemtrak-Selfcare deal. I've been reading their
press releases and if it isn't a quarterly report of losses, it's a release
announcing an offer of additional shares. Any thoughts on how SLF''s
situation will impact Chemtrak (if at all)? Or are their finances just
a reflection of an agressive growth strategy which includes CMTR?
Appologies to all for the tangent.

Bill

p.s. Still holding onto all my CMTR shares. Did you know that Hp Chek will be pushed with a sales force of 800 v.s. Quidel's product getting pushed with a sales force of 300 (P+G's)? HA! Don't ask. I forget where I read about the 800. Probably was an Astra-Merck release. Plus, Hp Chek should have that CLIA waiver soon.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext